The Purse
The Purse
Ovarian aging: an underinvested market. Can you delay menopause? 1 in 5 female pensioners live in poverty. Listen to our podcast with Mary Waring about how to manage your money in marriage & divorce
0:00
-1:18

Ovarian aging: an underinvested market. Can you delay menopause? 1 in 5 female pensioners live in poverty. Listen to our podcast with Mary Waring about how to manage your money in marriage & divorce

Welcome to our #85 weekly newsletter.

“For women taking control of their financial future”

-Jana Hlistova


From The Purse


In this week’s newsletter, we focus on a report on ovarian aging published by think tank, First Longevity.

The ovary is the earliest aging organ in women and is considered a ‘pacemaker’ of the female body aging. The implications on women’s lifespan and quality of life are therefore significant.

So why haven’t we seen more scientific discovery and investment in this space?

And according to Age UK, one in five female pensioners is living in poverty. We know that women, on average tend to have one fifth of the pension men do and their cost of care is much higher.

And don’t forget to listen to The Purse Podcast interview with Mary Waring, an independent financial advisor. We talk about how to manage your money in marriage and divorce.

You can review the news in brief so you stay on top of global financial, economic and investing trends.

I hope you enjoy this week’s newsletter.

Until next week,

Jana


Ovarian aging: an underinvested market. Can you delay menopause?

Women’s health has been underresearched and underinvested. Time for change.


Women don’t have many options when it comes to extending fertility and delaying menopause. This is in part due to women’s health still being considered a niche market which has led to less scientific discovery and less investment over time.

Today’s solutions focus on addressing the consequences of infertility as opposed to the prevention. Think assisted reproductive technologies such as IVF and hormone replacement therapy (which also carries high cancer risk).

But according to a new report on ovarian aging by think tank First Longevity, 32% of women aged 18-44 years would take a form of treatment or intervention drug to delay menopause and extend fertility.

Here are a few key facts:

  • Women’s life expectancy has increased by 30 years but menopause onset only by 3 to 4 years

  • By 2018, the number of women having their first child after the age of 35 has increased ten fold since 1970

  • Women may live 34% of their life in poor health compared to 26% for men.

  • During the first year of menopause, women lose 80% of estrogen.

The ovary is the earliest aging organ

… in women and is considered a ‘pacemaker’ of the female body aging-and the implications are significant.

The withdrawal of hormones during menopause often impacts a woman’s health in later life.

Menopause has been linked to increased risk of cardiovascular disease, osteoporosis and could even increase the risk of Alzheimer's Disease.

Shocking, right?

The costs to women and businesses (are real)

  • 13m women are currently in menopause (UK)

  • 1bn+ women globally will be in menopause by 2025

  • Every woman will experience menopause which lasts 4-10 years

It costs women an average $20k in trial-and-error spending on prescriptions, doctor visits, treatments, devices and products. 

Many senior women leave the workplace in their 50s because of the menopause- whether they are aware of it or not. Ironically, this is often at the peak of their career.

Meanwhile businesses haemorrhage experienced female talent and money (because of it). And often remain in the dark about why senior women are leaving the workplace.

A 2019 survey by the Chartered Institute of Personnel and Development found almost 900,000 women in the UK left the workforce due to menopausal symptoms.

And the highest rates of suicide and divorce is for women aged 51-54 years-the menopausal age.

But, even though women control 80% of all healthcare buying and usage decisions in a $3.5tn healthcare industry…

…the menopause market is hugely underinvested.

80% of health VCs (mostly male) have never invested in women’s health. And reproductive healthcare still makes up 95% of the femtech investment space.

The menopause market only makes up 5% of femtech investment (despite it being valued at $600bn+, according to the Female Founders Fund).

This is one of the many reasons why…

… we need more female investors making decisions about where to allocate capital. Research proves that gender-balanced investment teams outperform.

But crucially, women apply a new lens to investing and represent the lived experience and perspective of 50%+ of the population.

Ovarian aging research and interventions

According to the First Longevity report, most interventions have been tested on ‘model organisms’ (only) such as mice, but very few have gone to clinical trials and tested on human beings:

  • Supplementation: for example, curcumin, the active ingredient extracted from tumuric, has been shown to prevent rat ovaries from damage.

  • Caloric restriction: a dietary intervention which is generally considered to prolong lifespan, could delay ovarian aging.

  • Repurposed drugs: for example, a hormone that is available on prescription in the UK, melatonin, could be promising treatment for ovarian aging due to its antioxidant properties.

  • New methods in longevity: including platelet-rich plasma (PRP) has been implemented in regenerative medicine in the last 10 years. Stem cell treatment is another method that is being investigated. Molecular targets could also be used in targeting ovarian aging.

What next?

Share


News in Brief


Financial news

Crypto: bitcoin, ethereum & DeFi


Female pensioners: 1 in 5 live in poverty

Age UK released the findings as MPs prepare to debate the suspension of the triple lock in Parliament


According to Age UK, one in five female pensioners is living in poverty, as reported by The Independent.

In fact, the number of female pensioners living in poverty has increased from 14% (2012/13) to 20% (2019/20).

Age UK released the findings as MPs prepare to debate the suspension of the triple lock in Parliament (the triple lock ensures that pensions grow in line with whichever is highest out of earnings, inflation or 2.5%).

Based on the survey, here are some key stats:

  • 1.25m women in this group are now living below the breadline

  • Single female pensioners are at much higher risk of being in poverty than single men and pensioner couples

  • Pensioners from black and Asian communities (including men and women) are around twice as likely to be living in poverty as white pensioners

  • Male and female pensioners who rent their homes are also much more likely to be in poverty than those who own their home outright.

Based on research, women on average, tend to have one fifth of the pension men do and their cost of care is much higher.

However, according to the Department of Work and Pensions, ‘..pension reforms including auto-enrolment has helped millions more women save into a pension, many for the first time. Pension participation among eligible women working in the private sector has risen from 40% in 2012, to 86% in 2019’.

Read more here:


The Purse Podcast


Marriage and divorce: how to manage your money

We cover the following in our conversation:

  • Income vs net worth

  • Common money mistakes

  • Managing your money in marriage and divorce

  • Financial advisors: how they can help

  • How women can build their wealth

  • and more

Listen on all podcasting channels including iTunes and Spotify.


Coffee Break? Read This



We’d love to hear from you. Get in touch with Jana via the The Purse website or tweet @jointhepurse and @janicka.

The Purse Ltd. Copyright 2021 & All Rights Reserved.

The Purse provides content for informational purposes only, we do not recommend products or services or provide investment advice. Please do your own research or speak to a financial advisor.

Share The Purse


0 Comments